MWF-Chr 6SHR/Rkb |
systolic blood pressure |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
arterial blood pressure trait |
not specified |
173 days
| 19 |
|
151.0 |
mmHg |
1.6 |
6.97 |
tail cuff piezoplethysmography |
0.0 |
0 |
12-18 recordings on 3 consecutive days |
|
11689 |
117 |
MWF-Chr 6SHR/Rkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
urine albumin amount |
not specified |
56 days
| 19 |
|
0.7 |
mg/d |
0.1 |
0.44 |
enzyme linked immunosorbent assay |
0.0 |
0 |
|
|
65272 |
117 |
MWF-Chr 6SHR/Rkb |
serum creatinine level |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
blood creatinine amount |
female |
168 days
| 20 |
|
0.48 |
mg/dl |
0.01 |
0.06 |
serum creatinine analysis |
0.0 |
0 |
|
|
68176 |
309 |
MWF-Chr 6SHR/Rkb |
both kidneys wet weight |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
kidney mass |
female |
168 days
| 20 |
|
1.3 |
g |
0.05 |
0.22 |
post excision weight measurement |
0.0 |
0 |
|
|
68170 |
309 |
MWF-Chr 6SHR/Rkb |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
vasodilation trait |
male |
84 days
| 10 |
|
64.0 |
% |
3.8 |
12.02 |
wire myography |
0.0 |
0 |
|
|
109371 |
3141 |
MWF-Chr 6SHR/Rkb |
norepinephrine-induced blood vessel contractile force expressed as percent of force of contraction to KCL |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
vasoconstriction trait |
male |
84 days
| 10 |
|
128.2 |
% |
17.0 |
53.76 |
wire myography |
0.0 |
0 |
|
norepinephrine-induced blood vessel contractile force expressed as percent of force at baseline (CMO:0003676) |
109381 |
3141 |
MWF-Chr 6SHR/Rkb |
number of glomeruli per kidney to number of ureteric bud tips per kidney ratio |
control condition |
Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. |
kidney glomerulus quantity |
not specified |
-6 days
| 12 |
|
0.59 |
null |
0.03 |
0.12 |
immunofluorescence confocal microscopy |
0.0 |
0 |
immunofluorescence confocal microscopy with digital image analysis (MMO:0000751) |
number of glomeruli per kidney to number of ureteric bud tips per kidney ratio (CMO:0003849) |
109521 |
3145 |
MWF-Chr 6SHR/Rkb |
urine albumin level to urine low molecular weight protein ratio |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
urine albumin amount |
not specified |
168 days
| 19 |
|
159.0 |
% |
42.0 |
183.07 |
gel electrophoresis |
0.0 |
0 |
|
|
65356 |
117 |
MWF-Chr 6SHR/Rkb |
body weight |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
body mass |
not specified |
168 days
| 19 |
|
375.0 |
g |
8.9 |
38.79 |
body weighing method |
0.0 |
0 |
|
|
65359 |
117 |
MWF-Chr 6SHR/Rkb |
both kidneys wet weight |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
kidney mass |
not specified |
168 days
| 19 |
|
2.11 |
g |
0.07 |
0.31 |
post excision weight measurement |
0.0 |
0 |
|
|
65362 |
117 |
MWF-Chr 6SHR/Rkb |
kidney glomerulus count |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
kidney glomerulus quantity |
not specified |
28 days
| 7 |
N(glom)=1/SSF x 1/ASF x Ps/Pf x ΣQ-/2 |
34600.0 |
null |
5700.0 |
15080.78 |
ex vivo light microscopy with digital image analysis |
0.0 |
0 |
|
per kidney |
65398 |
117 |
MWF-Chr 6SHR/Rkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
urine albumin amount |
not specified |
98 days
| 19 |
|
48.8 |
mg/d |
41.7 |
181.77 |
enzyme linked immunosorbent assay |
0.0 |
0 |
|
|
65420 |
117 |
MWF-Chr 6SHR/Rkb |
count of superficial glomeruli directly contacting the kidney surface |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
kidney glomerulus quantity |
not specified |
168 days
| 19 |
|
1.6 |
null |
0.4 |
1.74 |
ex vivo light microscopy with digital image analysis |
0.0 |
0 |
|
per section |
65460 |
117 |
MWF-Chr 6SHR/Rkb |
serum urea nitrogen level |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
blood urea nitrogen amount |
not specified |
168 days
| 19 |
|
21.01 |
mg/dl |
0.7 |
3.05 |
serum urea analysis |
0.0 |
0 |
serum urea analysis |
|
65380 |
117 |
MWF-Chr 6SHR/Rkb |
fetal body weight |
control condition |
Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. |
body mass |
not specified |
-6 days
| 12 |
|
0.27 |
g |
0.0 |
0.02 |
body weighing method |
0.0 |
0 |
|
|
109506 |
3145 |
MWF-Chr 6SHR/Rkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
urine albumin amount |
not specified |
98 days
| 19 |
|
2.9 |
mg/d |
3.5 |
15.26 |
enzyme linked immunosorbent assay |
0.0 |
0 |
|
|
65274 |
117 |
MWF-Chr 6SHR/Rkb |
serum creatinine level |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
blood creatinine amount |
not specified |
168 days
| 19 |
|
0.43 |
mg/dl |
0.02 |
0.08 |
serum creatinine analysis |
0.0 |
0 |
|
|
65374 |
117 |
MWF-Chr 6SHR/Rkb |
serum urea nitrogen level |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
blood urea nitrogen amount |
female |
168 days
| 20 |
|
19.27 |
mg/dl |
0.67 |
3.01 |
serum urea nitrogen analysis |
0.0 |
0 |
|
|
68179 |
309 |
MWF-Chr 6SHR/Rkb |
creatinine clearance to body weight ratio |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
glomerular filtration trait |
female |
168 days
| 20 |
|
0.37 |
ml/min/100g |
0.04 |
0.18 |
blood creatinine analysis |
0.0 |
0 |
|
|
68182 |
309 |
MWF-Chr 6SHR/Rkb |
body weight |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
body mass |
female |
168 days
| 20 |
|
214.4 |
g |
5.2 |
23.26 |
body weighing method |
0.0 |
0 |
|
|
12759 |
309 |
MWF-Chr 6SHR/Rkb |
serum triglyceride level |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
blood triglyceride amount |
not specified |
168 days
| 19 |
|
108.85 |
mg/dl |
0.88 |
3.86 |
serum triglyceride analysis |
0.0 |
0 |
serum triglyceride analysis |
|
65385 |
117 |
MWF-Chr 6SHR/Rkb |
systolic blood pressure |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
arterial blood pressure trait |
male |
84 days
| 10 |
|
151.0 |
mmHg |
1.6 |
5.06 |
tail cuff plethysmography |
0.0 |
0 |
|
|
109287 |
3141 |
MWF-Chr 6SHR/Rkb |
heart wet weight |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
heart mass |
not specified |
168 days
| 19 |
|
0.93 |
g |
0.02 |
0.09 |
post excision weight measurement |
0.0 |
0 |
|
|
65368 |
117 |
MWF-Chr 6SHR/Rkb |
both kidneys wet weight to body weight ratio |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
kidney mass |
female |
168 days
| 20 |
|
6.06 |
g/kg |
0.16 |
0.72 |
post excision weight measurement |
0.0 |
0 |
|
|
12764 |
309 |
MWF-Chr 6SHR/Rkb |
systolic blood pressure |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
arterial blood pressure trait |
female |
168 days
| 20 |
|
139.0 |
mmHg |
1.6 |
7.16 |
tail cuff plethysmography |
0.0 |
0 |
|
|
68173 |
309 |
MWF-Chr 6SHR/Rkb |
negative logarithm of the molar concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
vasoconstriction trait |
male |
84 days
| 10 |
|
8.1 |
null |
0.1 |
0.32 |
wire myography |
0.0 |
0 |
|
logarithm of the concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value (CMO:0003677) |
109386 |
3141 |
MWF-Chr 6SHR/Rkb |
fetal body weight |
control condition |
Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. |
body mass |
not specified |
-6 days
| 12 |
|
0.27 |
g |
0.01 |
0.02 |
body weighing method |
0.0 |
0 |
|
|
109505 |
3145 |
MWF-Chr 6SHR/Rkb |
body length, crown to rump |
control condition |
Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. |
body length |
not specified |
-6 days
| 12 |
|
13.0 |
mm |
0.29 |
1.0 |
body length measuring method |
0.0 |
0 |
|
body length, crown to rump (CMO:0003847) |
109512 |
3145 |
MWF-Chr 6SHR/Rkb |
number of glomeruli per kidney |
control condition |
Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. |
kidney glomerulus quantity |
not specified |
-6 days
| 12 |
|
37.0 |
null |
1.73 |
6.0 |
immunofluorescence confocal microscopy |
0.0 |
0 |
immunofluorescence confocal microscopy with digital image analysis (MMO:0000751) |
|
109515 |
3145 |
MWF-Chr 6SHR/Rkb |
creatinine clearance to body weight ratio |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
glomerular filtration trait |
not specified |
168 days
| 19 |
|
0.59 |
ml/min/100g |
0.04 |
0.17 |
blood creatinine analysis |
0.0 |
0 |
|
|
65378 |
117 |
MWF-Chr 6SHR/Rkb |
serum total cholesterol level |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
blood cholesterol amount |
not specified |
168 days
| 19 |
|
74.52 |
mg/dl |
2.32 |
10.1 |
serum total cholesterol measurement test |
0.0 |
0 |
serum triglyceride analysis |
|
65390 |
117 |
MWF-Chr 6SHR/Rkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
urine albumin amount |
female |
168 days
| 0 |
|
1.7 |
mg/d |
|
|
enzyme linked immunosorbent assay |
0.0 |
0 |
|
|
69946 |
309 |
MWF-Chr 6SHR/Rkb |
urine albumin level to urine low molecular weight protein ratio |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
urine albumin amount |
not specified |
98 days
| 19 |
|
950.0 |
% |
55.0 |
239.74 |
gel electrophoresis |
0.0 |
0 |
|
|
65357 |
117 |
MWF-Chr 6SHR/Rkb |
heart weight to body weight ratio |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
heart mass |
female |
168 days
| 20 |
|
3.08 |
g/kg |
0.1 |
0.45 |
post excision weight measurement |
0.0 |
0 |
|
|
12766 |
309 |
MWF-Chr 6SHR/Rkb |
count of superficial glomeruli not directly contacting the kidney surface |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
kidney glomerulus quantity |
not specified |
168 days
| 19 |
|
15.2 |
null |
1.1 |
4.79 |
ex vivo light microscopy with digital image analysis |
0.0 |
0 |
|
per section |
65457 |
117 |
MWF-Chr 6SHR/Rkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
urine albumin amount |
not specified |
168 days
| 19 |
|
16.6 |
mg/d |
15.2 |
66.26 |
enzyme linked immunosorbent assay |
0.0 |
0 |
|
|
65276 |
117 |
MWF-Chr 6SHR/Rkb |
both kidneys wet weight to body weight ratio |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
kidney mass |
not specified |
168 days
| 19 |
|
5.62 |
g/kg |
0.18 |
0.78 |
post excision weight measurement |
0.0 |
0 |
|
|
65365 |
117 |
MWF-Chr 6SHR/Rkb |
number of ureteric bud tips per kidney |
control condition |
Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. |
ureteric bud morphology trait |
not specified |
-6 days
| 12 |
|
64.0 |
null |
3.46 |
12.0 |
immunofluorescence confocal microscopy |
0.0 |
0 |
immunofluorescence confocal microscopy with digital image analysis (MMO:0000751) |
number of ureteric bud tips per kidney (CMO:0003848) |
109518 |
3145 |
MWF-Chr 6SHR/Rkb |
heart wet weight |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
heart mass |
female |
168 days
| 20 |
|
0.66 |
g |
0.03 |
0.13 |
post excision weight measurement |
0.0 |
0 |
|
|
12765 |
309 |
MWF-Chr 6SHR/Rkb |
heart weight to body weight ratio |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
heart mass |
not specified |
168 days
| 19 |
|
2.47 |
g/kg |
0.05 |
0.22 |
post excision weight measurement |
0.0 |
0 |
|
|
65371 |
117 |